BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gu GS, Ren JA, Li N, Li JS. Effects of recombinant human growth hormone on enterocutaneous fistula patients. World J Gastroenterol 2008; 14(44): 6858-6862 [PMID: 19058314 DOI: 10.3748/wjg.14.6858]
URL: https://www.wjgnet.com/1007-9327/full/v14/i44/6858.htm
Number Citing Articles
1
Nurten Turhan Haktanır, Güray Yılmaz, Mehmet Fatih Bozkurt, Yavuz Demir. Effects of insulin-like growth factor-1 on random pattern skin flap survival in ratsActa Cirurgica Brasileira 2016; 31(8): 513 doi: 10.1590/S0102-865020160080000003
2
Yan Lin, Suyi Li, Peng Cao, Lu Cheng, Ming Quan, Suyu Jiang. The effects of recombinant human GH on promoting tumor growth depend on the expression of GH receptor in vivoJournal of Endocrinology 2011; 211(3): 249 doi: 10.1530/JOE-11-0100
3
Xiuwen Wu, Jianan Ren, Guosheng Gu, Gefei Wang, Gang Han, Bo Zhou, Huajian Ren, Min Yao, Vickie R. Driver, Jieshou Li. Autologous platelet rich fibrin glue for sealing of low-output enterocutaneous fistulas: An observational cohort studySurgery 2014; 155(3): 434 doi: 10.1016/j.surg.2013.09.001
4
Nurten Kucuk, Murat Sari, Ahmet Midi, Ali Cemal Yumusakhuylu, Ozan Findik, Adem Binnetoglu. Effectiveness of Recombinant Human Growth Hormone for Pharyngocutaneous Fistula ClosureClinical and Experimental Otorhinolaryngology 2015; 8(4): 390 doi: 10.3342/ceo.2015.8.4.390
5
Jianan Ren, Yujie Yuan, Yunzhao Zhao, Guosheng Gu, Gefei Wang, Jun Chen, Chaogang Fan, Xinbo Wang, Jieshou Li. Open Abdomen Treatment for Septic Patients with Gastrointestinal Fistula: From Fistula Control to Definitive ClosureThe American Surgeon™ 2014; 80(4): 339 doi: 10.1177/000313481408000414